Jundishapur Journal of Microbiology

Published by: Kowsar

Attenuation and Production of the Amphotericin B-Resistant Leishmania tropica Strain

Imran Khan 1 , 2 , Momin Khan 2 , Muhammad Naveed Umar 3 and Deog-Hwan Oh 1 , *
Authors Information
1 Department of Food Science and Biotechnology, College of Agriculture and Life Sciences, Kangwon National University, Chuncheon, Republic of Korea
2 Department of Biotechnology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabd, Pakistan
3 Department of Chemistry, University of Malakand, Chakdara, Pakistan
Article information
  • Jundishapur Journal of Microbiology: June 01, 2016, 9 (6); e32159
  • Published Online: May 14, 2016
  • Article Type: Research Article
  • Received: August 6, 2015
  • Revised: January 27, 2016
  • Accepted: April 4, 2016
  • DOI: 10.5812/jjm.32159

To Cite: Khan I, Khan M, Umar M N, Oh D. Attenuation and Production of the Amphotericin B-Resistant Leishmania tropica Strain, Jundishapur J Microbiol. 2016 ; 9(6):e32159. doi: 10.5812/jjm.32159.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kamhawi S. Phlebotomine sand flies and Leishmania parasites: friends or foes? Trends Parasitol. 2006; 22(9): 439-45[DOI][PubMed]
  • 2. Mishra BB, Singh RK, Srivastava A, Tripathi VJ, Tiwari VK. Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents. Mini Rev Med Chem. 2009; 9(1): 107-23[PubMed]
  • 3. Singh N, Kumar M, Singh RK. Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pac J Trop Med. 2012; 5(6): 485-97[DOI][PubMed]
  • 4. Fragaki K, Ferrua B, Mograbi B, Waldispuhl J, Kubar J. A novel Leishmania infantum nuclear phosphoprotein Lepp12 which stimulates IL1-beta synthesis in THP-1 transfectants. BMC Microbiol. 2003; 3: 7[DOI][PubMed]
  • 5. Alizadeh R, Hooshyar H, Bandehpor M, Arbabi M, Kazemi F, Talari A, et al. Detection of drug resistance gene in cutaneous leishmaniasis by PCR in some endemic areas of iran. Iran Red Crescent Med J. 2011; 13(12): 863-7[PubMed]
  • 6. Escobar P, Matu S, Marques C, Croft SL. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop. 2002; 81(2): 151-7[PubMed]
  • 7. Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T, et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol. 2003; 48(6): 893-6[DOI][PubMed]
  • 8. Perez-Victoria JM, Perez-Victoria FJ, Parodi-Talice A, Jimenez IA, Ravelo AG, Castanys S, et al. Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator. Antimicrob Agents Chemother. 2001; 45(9): 2468-74[PubMed]
  • 9. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson AD. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet. 1991; 337(8749): 1061-2[PubMed]
  • 10. Mishra M, Biswas UK, Jha DN, Khan AB. Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet. 1992; 340(8830): 1256-7[PubMed]
  • 11. Russo R, Nigro LC, Minniti S, Montineri A, Gradoni L, Caldeira L, et al. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J Infect. 1996; 32(2): 133-7[PubMed]
  • 12. Khan I, Khan M, Umar MN, Oh DH. Nanobiotechnology and its applications in drug delivery system: a review. IET Nanobiotechnol. 2015; 9(6): 396-400[DOI][PubMed]
  • 13. Ali KS, Rees RC, Terrell-Nield C, Ali SA. Virulence loss and amastigote transformation failure determine host cell responses to Leishmania mexicana. Parasite Immunol. 2013; 35(12): 441-56[DOI][PubMed]
  • 14. Guidance on the Operation of the Animals (Scientific Procedures). 1986;
  • 15. Imran K, Muhammad NU. Evaluation of Crude Extract of Melia azedarach Linn. Against Attenuated Amphotericin B Resistant Leishmania tropica Strain. J Basic Appl Sci. 2015; 11: 314-7[DOI]
  • 16. Khan I, Yasinzai MM, Mehmood Z, Ilahi I, Khan J, Khalil A, et al. Comparative study of green fruit extract of Melia azedarach Linn. with its ripe fruit extract for antileishmanial, larvicidal, antioxidant and cytotoxic activity. Am J Phytomed Clin Ther. 2014; 2(3): 442-54
  • 17. Arana FE, Perez-Victoria JM, Repetto Y, Morello A, Castanys S, Gamarro F. Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica. Biochem Pharmacol. 1998; 56(9): 1201-8[PubMed]
  • 18. Mbongo N, Loiseau PM, Billion MA, Robert-Gero M. Mechanism of amphotericin B resistance in Leishmania donovani promastigotes. Antimicrob Agents Chemother. 1998; 42(2): 352-7[PubMed]
  • 19. Haimeur A, Ouellette M. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate. Antimicrob Agents Chemother. 1998; 42(7): 1689-94[PubMed]
  • 20. Seifert K, Matu S, Javier Perez-Victoria F, Castanys S, Gamarro F, Croft SL. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int J Antimicrob Agents. 2003; 22(4): 380-7[PubMed]
  • 21. Grondin K, Kundig C, Roy G, Ouellette M. Linear amplicons as precursors of amplified circles in methotrexate-resistant Leishmania tarentolae. Nucleic Acids Res. 1998; 26(14): 3372-8[PubMed]
  • 22. Olmo A, Arrebola R, Bernier V, Gonzalez-Pacanowska D, Ruiz-Perez LM. Co-existence of circular and multiple linear amplicons in methotrexate-resistant Leishmania. Nucleic Acids Res. 1995; 23(15): 2856-64[PubMed]
  • 23. Hart DT, Lauwers WJ, Willemsens G, Vanden Bossche H, Opperdoes FR. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Mol Biochem Parasitol. 1989; 33(2): 123-34[PubMed]
  • 24. Schaffner A, Bohler A. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism. Mycoses. 1993; 36(11-12): 421-4[PubMed]
  • 25. Joseph-Horne T, Manning N, Holoman D, Kelly S. Nonsterol related resistance in Ustilago maydis to the polyene antifungals, amphotericin B and nystatin. Phytochemistry. 1996; 42(3): 637-9[PubMed]
  • 26. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation. FEBS Lett. 1997; 400(1): 80-2[PubMed]
  • 27. Yao C, Gaur Dixit U, Barker JH, Teesch LM, Love-Homan L, Donelson JE, et al. Attenuation of Leishmania infantum chagasi metacyclic promastigotes by sterol depletion. Infect Immun. 2013; 81(7): 2507-17[DOI][PubMed]
  • 28. Chang KP, McGwire BS. Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol Dis. 2002; 1(1): 1[PubMed]
  • 29. Smith H. The development of studies on the determinants of bacterial pathogenicity. J Comp Pathol. 1988; 98(3): 253-73[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments